Who founded Vascudyne?

Vascudyne was founded by Robert T. Tranquillo, Zeeshan Syedain in 2014.

How much funding has Vascudyne raised?

Vascudyne has disclosed $19.6M raised across 2 rounds.

Where is Vascudyne headquartered?

Vascudyne is headquartered in Plano, US.

Vascudyne

Plano, US · Founded 2014 · Delaware corporation

Find your way into Vascudyne

150 people in our graph share verified history with the Vascudyne team — schools, employers, funds. One of them is your warm intro.

Isaac Zikeunlockedknows Zeeshan Syedain · together at University of Minnesota (overlapped)

×11knows the team · via University of Minnesota

Vascudyne develops allograft tissue engineered from biological materials for regenerative medical applications, including heart valve therapies. The company advances non-immunogenic tissue solutions for clinical use.

Biotech Healthtech Medical Devices

Founders & leadership

Vascudyne was founded in 2014 by Robert T. Tranquillo and Zeeshan Syedain.

Robert T. TranquilloDirector of Congenial Heart Regeneration Program

Zeeshan Syedain CEOZeeshan Syedain is CEO of Vascudyne and co-inventor of bioengineered tissue technology developed at the University of Minnesota. He brings experience in medical device development, regulatory strategy, and clinical translation across cardiovascular applications.

Kemal SchakereliExecutive

Jeffrey D. FrancoExecutive

Jim NessExecutive

Reported raises · per SEC filings

Form D private placements

$19.6M disclosed across 2 rounds · 2015–2021

▶$17.7MraisedOct 2021 · 31 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Claude AmosDirector
Kemal SchankereliExecutive Officer, Director

Offering amount: $17.7M
Amount sold: $17.7M
Finders' fees: $506.2K
Placement agents: CSCAP ApS, Mirabaud Securities Ltd
First sale: Oct 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.9MraisedMar 2017 · 3 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Kemal SchakereliExecutive Officer, Director
Jeffrey D. FrancoExecutive Officer, Director
Jim NessExecutive Officer

Offering amount: $1.9M
Amount sold: $1.9M
Minimum investment: $1
First sale: Jun 2015
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Seamless11 shared keywordsSeamless is a revenue operations platform that uses AI to automate sales outreach and contact verification for sales, marketing, and customer success teams. It identifies target buyers, verifies contact information in real time, and orchestrates multi-channel outreach via email, phone, and social media to generate meetings and pipeline.

Companies competing with Vascudyne for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

University of Minnesota spinoff Vascudyne raises $10M to expand organic heart valve tech - Minneapolis / St. Paul Business Journalbizjournals.com · Dec 2021

Minnesota spawns Vascudyne -globalventuring.com · Dec 2018

Frequently asked questions

What does Vascudyne do?: Vascudyne develops allograft tissue engineered from biological materials for regenerative medical applications, including heart valve therapies. The company advances non-immunogenic tissue solutions for clinical use.
Who founded Vascudyne?: Vascudyne was founded by Robert T. Tranquillo, Zeeshan Syedain in 2014.
How much funding has Vascudyne raised?: Vascudyne has disclosed $19.6M raised across 2 rounds.
Where is Vascudyne headquartered?: Vascudyne is headquartered in Plano, US.